Silence Therapeutics

NASDAQ: SLN · Real-Time Price · USD
5.48
-0.15 (-2.66%)
At close: Aug 15, 2025, 3:59 PM
5.49
0.09%
After-hours: Aug 15, 2025, 04:10 PM EDT

Silence Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
43.26M 25.38M 17.5M 12.41M
Cost of Revenue
11.81M 10.32M 10.88M 7.46M
Gross Profit
31.45M 15.06M 6.62M 4.96M
Operating Income
-63.32M -49.6M -48.59M -45.81M
Interest Income
4.47M 1.45M 226K 10K
Pretax Income
-44.46M -50.31M -47.37M -45.86M
Net Income
-45.31M -43.27M -40.49M -39.41M
Selling & General & Admin
26.88M 20.64M 19.61M 20.01M
Research & Development
67.88M 44.02M 35.6M 30.77M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
94.77M 64.66M 55.21M 50.77M
Interest Expense
n/a 34K 47K 8K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
106.58M 74.98M 66.09M 58.23M
Income Tax Expense
845K -7.04M -6.88M -6.45M
Shares Outstanding (Basic)
47.22M 37.09M 32.19M 29.65M
Shares Outstanding (Diluted)
47.22M 37.09M 32.19M 29.65M
EPS (Basic)
-0.98 -1.17 -1.26 -1.32
EPS (Diluted)
-0.98 -1.17 -1.26 -1.32
EBITDA
-48.99M -49.78M -47.88M -45.42M
EBIT
-49.58M -50.28M -47.32M -45.85M
Depreciation & Amortization
593K 498K 482K 427K